Hale Therapeutics

General Information

Company Name

Hale Therapeutics

Founded Year

2019

Location (Offices)

Philadelphia, United States +1

Founders / Decision Makers

Number of Employees

Industries

Health Care, Health and Wellness, Medical Devices

Funding Stage

Series Unknown

Social Media

Hale Therapeutics - Company Profile

Hale Therapeutics is a health care startup founded in 2019 with a mission to end nicotine addiction. The company has developed a groundbreaking digital drug therapy device designed to mitigate the harm and risks associated with nicotine de-addiction. Based in the United States, Hale recently received a significant Venture Round investment on 01 January 2023, with the funding coming from Chaos Ventures. This investment reflects the growing recognition of Hale Therapeutics' potential to disrupt the health care industry and address a pressing global health issue.

Taxonomy: nicotine addiction, digital drug therapy, de-addiction, low-harm, low-risk, health technology, smoking cessation, nicotine replacement therapy, behavioral therapy, digital health, medical device, addiction treatment, health tech startup, smoking cessation device

Funding Rounds & Investors of Hale Therapeutics (4)

View All

Funding Stage	Amount	No. Investors	Investors	Date
Venture Round	Unknown	1		01 Jan 2023
Seed Round	$50.00K	2		10 Nov 2021
Pre Seed Round	Unknown	1	Harrison Uffindell	01 Nov 2020
Pre Seed Round	$1.70M	6	MiLA Capital (Make in LA), Todd Jackson +1	13 Nov 2019